抗衰老的干细胞治疗——从细胞层面支持活力与未病对策

衰老不仅体现在皮肤，更源于细胞层面的功能下降。护肤品、保健品与激素补充难以从根本上改变生物学年龄。自体脂肪来源干细胞（ADSC）治疗作为抗衰老与未病对策的一环受到关注。本文由日本大阪Cell Grand Clinic的医师解说。

身体为何会衰老

衰老与慢性炎症、干细胞功能下降、细胞衰老堆积、组织修复力减弱等多种因素相关。间充质干细胞具有抗炎与调节免疫的作用，被认为有助于改善这一整体环境。

干细胞能”逆转”衰老吗

目前不能保证”逆转衰老”。研究提示间充质干细胞在虚弱（frailty）、疲劳感、整体活力等方面具有潜力，但仍处于研究阶段，效果因人而异，应理解为在健康管理基础上的补充选择。

证据与现状

关于间充质干细胞用于抗衰老与虚弱的临床研究正在推进，多项报告提示其在安全性方面表现良好。现阶段仍缺乏大规模长期数据，需理性看待。

为什么选择日本、选择Cell Grand Clinic

本院将抗衰老与未病对策以已登记的”虚弱（フレイル）”再生医疗提供计划（PB5250049）为依据合规运营，采用2亿个自体ADSC结合外泌体的全身方案。厚生劳动省登记的提供计划共15项。特点包括：

仅使用自体细胞，排异风险极低；
细胞品质标准化（ISCT鉴定、活性95%以上、P3以内）；
由ABRM专科医师、逾3,000例经验的若林院长全程负责；院长本人也接受干细胞与外泌体治疗；
英语直接沟通，并提供中文（微信）对接。

与NMN、激素等的区别

NMN与激素补充各有作用，但主要针对单一通路。干细胞治疗着眼于炎症与修复环境这一更上游的层面，可与其他方案互补。

治疗流程

赴日仅需两次、每次约2–3天；约7周培养期间可在本国等待；回输后1/3/6个月随访由医师远程跟进。心斋桥站步行5分钟，距关西国际机场约50分钟。

常见问题

Q. 能延长寿命吗？
无法做出此类保证。它着眼于活力与身体状态的整体支持，效果因人而异。

Q. 安全吗？
使用自体细胞，排异风险极低；本院对品质与流程严格管理。

从细胞层面开始的抗衰老

如果您对针对未病与抗衰老的再生医疗感兴趣，欢迎联系我们，由医师为您评估是否适合。

【Author information】

Dr. Yuichi Wakabayashi, Medical Director of Cell Grand Clinic

Yuichi Wakabayashi, M.D., Ph.D.

Medical Director, Cell Grand Clinic
Diplomate, American Board of Regenerative Medicine (ABRM)

【About the Author】
Dr. Yuichi Wakabayashi is a regenerative medicine specialist with over 3,000 stem cell treatments performed. After earning his M.D. and Ph.D. at Kobe University, he conducted research at the U.S. National Institutes of Health (NIH) in the field of neurological disorders. His international achievements include first-author publication of the world's first-in-human PDE4B-specific PET tracer study, conducted in collaboration with Pfizer Inc. As Medical Director of Cell Grand Clinic, he combines evidence-based science with rigorous safety standards, dedicated to extending each patient's healthy lifespan through advanced regenerative medicine.

【Specialties】
Regenerative medicine (stem cell therapy) / Anti-aging medicine / Preventive medicine / Aesthetic regenerative medicine

【Board Certifications & Memberships】
Diplomate, American Board of Regenerative Medicine (ABRM) / Board-Certified Specialist, Japan Society of Anti-Aging Medicine / Board-Certified Specialist, Diagnostic Radiology (Japan) / Board-Certified Specialist, Nuclear Medicine (Japan) / Member, Japanese Society for Regenerative Medicine / Member, Japan Society for Dementia Research

【Education & Career】
Kobe University School of Medicine (M.D.) → Kobe University Graduate School (Ph.D.) → Kindai University School of Medicine (Lecturer) → U.S. National Institutes of Health (Research Fellow) → Cell Grand Clinic (Medical Director)

【Publications & Media】
Author: "The Simplest Guide to Regenerative Medicine" (book) / Featured in The Wall Street Journal (U.S.) / Featured on KBS Kyoto Television (Japan) / Multiple publications in international peer-reviewed journals

【Clinical Experience】
Over 3,000 stem cell treatments performed — including osteoarthritis, diabetes, chronic pain, frailty, erectile dysfunction, hair loss, and aesthetic rejuvenation

【Supervisory Statement】
The medical content of this article is supervised by the Medical Director of Cell Grand Clinic — a facility that has filed Type 2 and Type 3 Regenerative Medicine Provision Plans with Japan's Ministry of Health, Labour and Welfare (MHLW) under the Act on the Safety of Regenerative Medicine (Plan No.: PB5240089 and others), following review by an MHLW-Certified Special Committee for Regenerative Medicine. We are committed to providing accurate, evidence-based health information.

Google Scholar Profile ORCID researchmap Wikidata

ALL COLUMN